This trial is for adults w/ depression who haven't had relief from other treatments. The goal is to see if a new medicine, BI 1569912, is effective & tolerable. People are randomly assigned to take BI 1569912 or a placebo, & doctors monitor their health for 5 weeks.
- Major Depressive Disorder
2 Primary · 1 Secondary · Reporting Duration: Up to Day 15
2 Treatment Groups
BI 1569912 treatment group
1 of 2
1 of 2
66 Total Participants · 2 Treatment Groups
Primary Treatment: BI 1569912 · Has Placebo Group · Phase 1
Who is running the clinical trial?
Age 18 - 65 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment in this experiment still available for participants?
"Clinicaltrials.gov provides evidence that this clinical trial is actively enrolling participants; the trial was initiated on July 20th 2021 and lastly updated November 28th 2022." - Anonymous Online Contributor
Has BI 1569912 been cleared by the FDA for public use?
"The safety of BI 1569912 is estimated to be a 1 due to the limited information provided by Phase 1 studies, which are unable to provide sufficient evidence for efficacy and safety." - Anonymous Online Contributor
How many individuals are contributing to this research endeavor?
"This clinical trial requires 66 individuals who meet the set criteria for inclusion. Enrolment can take place at InSite Clinical Research in Hollywood, Texas and Collaborative Neuroscience Network, LLC (CNS) in DeSoto, California." - Anonymous Online Contributor
Might I be eligible to participate in this experiment?
"To be eligible for this medical trial, potential participants must experience psychosis and involutional aging. The age constraints are 18-65 years old. 66 individuals will ultimately be chosen to partake in the study." - Anonymous Online Contributor
Are there numerous health care centers conducting this experiment in North America?
"This trial is currently taking place in 6 different sites, two of which are located in Hollywood and DeSoto respectively. Additionally, Garden Grove offers another site while the other 3 centres can be found elsewhere. Participants should select the closest medical centre to reduce travelling times if they choose to join this experiment." - Anonymous Online Contributor
Does this clinical trial include elderly individuals in its recruitment?
"Patients aged 18 to 65 are eligible for this trial. For those below the age of consent, there is a current list of 191 trials; conversely, older patients can find 964 suitable studies." - Anonymous Online Contributor